Joerg Riesmeier

Part of SAVIA SA de CV, DNA Plant Technology Corp. is engaged in testing for improved agriculture. The company is based in Riverton, NJ.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Lightfull Foods, Inc. provides snacks and food products. Its products include drinkable yogurt, cafe lattes, dutch chocolates, peachy creams, and strawberries. The company was founded by Lynn Graham, Pete Mattson and Lara Jackle and is headquartered in San Francisco, CA

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

SunPure Ltd. produces frozen concentrate orange and grapefruit juice. The company is headquartered in Lakeland, FL.

Part of International Flavors & Fragrances, Inc., Cultor Food Science, Inc. is a British company that manufactures food preservatives.

Part of DSM-Firmenich AG, Martek Biosciences Boulder Corp. is a private company that produces and sells docosahexaenoic acid (DHA) products. Martek Biosciences Boulder Corp. is based in Boulder, CO. Martek Biosciences Boulder was acquired by Martek Biosciences Corp. on April 25, 2002 for $95.49 million.

IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany.

A.M. Todd Co. produces flavoring chemicals and products. It provides American peppermint and spearmint oil. The company was founded in 1869 and is headquartered in Kalamazoo, MI.

Part of International Flavors & Fragrances, Inc., Danisco USA, Inc. manufactures a food-coloring product line and related equipment. The company is based in Fairfield, NJ.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

Stolle Milk Biologics, Inc. operates as a research company for the benefits of milk. It specializes in natural consumer milk products, as well as ingredients used in the development of food, medicinal and nutritional supplement applications. The company was founded by Ralph Stolle in 1958 and is headquartered in West Chester, OH.

MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA.

INB: Hauser Pharmaceutical Services, Inc. develops chemical processes for the pharmaceutical and biopharmaceutical industries. It specializes in cytotoxic, next-generation chemotherapeutics, multi-step custom synthesis, and naturally derived actives. The company was founded on February 4, 2011 and is headquartered in Denver, CO.

EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands.

Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany.

Curexsys GmbH is a German company founded by molecular biologist Jens Gruber and biochemist Dr. Herbert Stadler. The company is based in Goettingen, Germany. The company aims to become a leading supplier for clinical grade exosomes in regenerative medicine and anti-aging therapies. Exosomes are extracellular, nanoscale vesicles that transfer information to neighboring cells and distant tissues. Curexsys is currently pursuing the development of several programs in three indications, focusing on the generation of clearly defined, characterized, and purified extracellular vesicles/exosomes from their proprietary iMSC lines derived from Evotec's iPSC platform.

Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.

Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.

Part of Astorg Asset Management SARL, Astorg VII Co-Invest CYTEL operates as a private equity fund. The company is based in Luxembourg, Luxembourg.

Part of Astorg Asset Management SARL, Astorg Asset Management UK provides investment fund management services. The company is based in London, UK and was founded in 2017.